Regeneron gets another CRL, predicts delayed August PDUFA for Eylea HDnews2025-08-01T11:37:56+00:00August 1st, 2025|Endpoints News|
FDA approves Lenz’s eye drop for presbyopia, a tricky market for other biopharmasnews2025-07-31T20:56:20+00:00July 31st, 2025|Endpoints News|
FDA chief wants more harmony between CBER and CDERnews2025-07-31T19:48:19+00:00July 31st, 2025|Endpoints News|
Prasad’s exit seen as positive for some biotechs, but uncertainty remainsnews2025-07-30T19:09:11+00:00July 30th, 2025|Endpoints News|
CDER director Tidmarsh will be acting head of FDA biologics center following Prasad exitnews2025-07-30T16:09:36+00:00July 30th, 2025|Endpoints News|
Vinay Prasad out at FDA after agency backtracks on Sarepta decisionnews2025-07-30T00:54:09+00:00July 30th, 2025|Endpoints News|
Senate confirms Susan Monarez to lead CDC for Trump administrationnews2025-07-29T22:28:26+00:00July 29th, 2025|Endpoints News|
Is the Sarepta mess what a political FDA looks like?news2025-07-29T13:31:27+00:00July 29th, 2025|Endpoints News|
FDA approves PTC’s rare genetic disease drugnews2025-07-29T12:58:43+00:00July 29th, 2025|Endpoints News|
Endpoints livestream: Is the Sarepta mess what a politicized FDA looks like?news2025-07-29T12:58:05+00:00July 29th, 2025|Endpoints News|
